Track topics on Twitter Track topics that are important to you
On Tuesday, Elliott Management Corporation (“Elliott”) released a letter to the Board of Directors of athenahealth, Inc. regarding Elliott’s proposal to acquire athenahealth for $160 per share ...
GREENVILLE, N.C., April 2, 2018/PRNewswire/ -- Elliott Squiresis recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Read more...
After Elliott Management sent a third letter to athenahealth urging it to consider the offer, the EHR vendor retorted with a statement of its own, noting it will take its time in evaluating the bid.
Investment firm Elliott Management has proposed acquiring Watertown, Mass.-based health IT vendor athenahealth in a deal worth nearly $7 billion.
In a letter to athenahealth’s board of directors, Elliott Management Partner Jesse Cohn makes his firm’s case for why the company would be better off as a private business.
Elliott makes $7B all-cash bid for Athenahealth nleider Mon, 05/07/2018 - 14:44 Teaser Media
Letter outlines concerns with athenahealth’s lack of engagement to date Full letter available at ElliottLetters.com/athenahealth Elliott Management Corporati...
Moves highlight new potential hypocrisies for dealing with cross-border transactions
In the original version of this article, author Ryan Elliott's name was misspelled as Ryan Eliott. The correct spelling of the name is Ryan Elliott.
Aquagenic wrinkling of the palms (AWP) is a condition characterized by oedema, confluent white papules and excessive wrinkling of the palms after few minutes exposure to water. The phenomenon may be a...
Elliot F. Ellis is indeed a giant in the field of allergy and immunology. From his leadership role in developing a pediatric allergy and immunology fellowship at National Jewish Health and his seminal...
Bidimensional attitudes have been shown to independently predict behaviour, with the positive dimension of attitude being a stronger predictor of behaviour than the negative dimension (e.g., Elliott, ...
Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of...
A multi-center, placebo controlled, double-blind trial comparing the efficacy and safety of 18 months of treatment with deferiprone versus placebo in patients with PKAN. This investigator...
FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air compressors with operations in over 90 countries. Building on a 50-year tradition o...
We have published hundreds of FS-Elliott news stories on BioPortfolio along with dozens of FS-Elliott Clinical Trials and PubMed Articles about FS-Elliott for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FS-Elliott Companies in our database. You can also find out about relevant FS-Elliott Drugs and Medications on this site too.